Screener
Guardian Pharmacy Services GRDN Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 21.6%+2.0pp | 20.9%+1.1pp | 20.2%+0.3pp | 19.7%-0.1pp | 19.6%-0.3pp | |
| Operating margin | 5.8%— | 5.3%— | 5%— | —— | —— | |
| Net margin | 4.5%+12.3pp | 3.6%+12.4pp | 3.4%+12.8pp | 2%+10.6pp | -7.8%-9.1pp | |
| Returns | ||||||
| Return on equity | 30.1%— | 26.8%— | 26.8%— | —— | —— | |
| Return on invested capital | 29.8%— | 27.4%— | 25.5%— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 3.7×— | 3.8×— | 4×-0.2× | 3.8×— | —— | |
| Liquidity | ||||||
| Current ratio | 1.7×+0.5× | 1.5×+0.3× | 1.4×+0.3× | 1.2×+0.1× | 1.2×— | |
| Leverage | ||||||
| Debt-to-equity | 0.1×-0.1× | 0.2×0.0× | 0.2×0.0× | —— | 0.2×— | |
| Net debt / EBITDA | -0.5×— | -0.3×— | -0.2×— | —— | —— | |
| Per Share | ||||||
| Book value per share | $4.04+42.0% | $3.65+40.7% | $3.44+42.3% | —— | $2.84— | |
| Valuation | ||||||
| Market capitalization | $2.58B+67.3% | $2.42B+80.1% | $1.91B+48.6% | $1.66B— | $1.3B— | |
| Price / earnings | 39.2×-15.4× | 45.7×— | 38.7×— | 58.7×— | —— | |
| Price / sales | 1.8×+0.7× | 1.7×+0.6× | 1.3×+0.3× | 1.2×— | 1×— | |
| Price / book | 10×— | 10.4×+2.2× | 8.7×+0.2× | —— | 7.3×— | |
| EV / EBITDA | 23.3×— | 23.9×— | 19.8×— | —— | —— |
FAQ
- What are Guardian Pharmacy Services's profit margins?
- Guardian Pharmacy Services (GRDN) runs a 21.6% gross margin and a 5.8% operating margin, with a 4.5% net margin.
- Where do Guardian Pharmacy Services's ratios come from?
- Every ratio is computed from Guardian Pharmacy Services's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
